BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ZYTO Corp. Announces Patent Approval


1/24/2012 9:08:43 AM

LINDON, UT--(Marketwire - January 23, 2012) -

ZYTO Corp (OTCBB: ZYTC) (www.ZYTO.com).

Today, ZYTO Corp, a Utah-based company specializing in biocommunication applications, announced that on January 17, 2012, it received confirmation from the United States Patent and Trademark Office ("USPTO") that the Company's patent application for "Methods and Devices for Analyzing and Comparing Physiological Parameter Measurements" (the "Patent") had been issued, and given Patent No. 8,099,159.

Vaughn R Cook, OMD, ZYTO's CEO, said, "The Patent covers the process used by ZYTO technology to measure the body's responses to computer stimuli."

As noted in the application for the Patent filed with the USPTO, the invention encompasses the methods and devices that can non-invasively monitor physiological parameters of multiple contact points before and after a stimulus is applied to a subject and compare the measured parameters to determine whether the physiological state of the subject is favorable or unfavorable.

The grant of the Patent follows the notification received from the US Food and Drug Administration in August 2011 that the Company's Premarket Notification, submitted pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act, had been approved.

According to Kami J. Howard, ZYTO's President, "This marks another milestone for ZYTO and is an indication of the value of our technology."

About ZYTO Corp

ZYTO Corp was founded by its CEO Dr. Vaughn R Cook, OMD. The company designs and builds computer technology to facilitate decision making about healthcare and wellness options.

For more information visit www.ZYTO.com or contact their Headquarters at 801-224-7199.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO's marketing partners, ZYTO product development launches, future growth and research, and enhanced value for ZYTO's stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release.


Seth Holdaway
Email Contact
801-224-7199



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES